I have been working with mast-cell stabilizers now for nearly a decade.
When I was diagnosed with histamine intolerance and mast cell activation syndrome, I could not tolerate any of the prescription mast-cell stabilizers.
That led me to research the list of 21 anti-histamine foods that fight inflammation and stabilize mast cells nearly seven years ago.
That list highlights butyrate as a proven mast-cell stabilizer.
Since then, I have understood the paramount importance of butyrate, which maintains homeostasis in the body, not just of our mast cells but also our cell function in general.
Butyrate is a type of short-chain fatty acid (SCFA).
SCFAs are the building blocks of fats that our cells need for energy. Without sufficient SCFAs, our cells do not have the energy to function.
Butyrate is produced mainly by our microbiome, where it provides the energy for the cells lining our intestine to function.
Around 5 – 10% of butyrate enters the bloodstream, where it circulates not only to maintain energy homeostasis but also for our brain to function.
Without sufficient butyrate, energy, gut, and brain, dis-homeostasis is inevitable.
Butyrate is produced mainly by our microbiota.
Butyrate is produced indirectly through:
Butyrate-producing bacteria typically belong to the firmicutes phylum. A detailed list of known butyrate-producing bacteria follows:
Of these, Faecalbacterium prausnitzii are significant butyrate-producers and amongst the most abundant bacteria in a healthy microbiome.
Interestingly, in an animal study, butyrate supplementation also directly altered the gut microbiota by increasing SCFA-producing bacteria and decreasing histamine-releasing bacteria.
Butyrate production will be hampered without sufficient butyrate-producing bacteria, the fiber in the diet, or a diverse and abundant microbiota.
Our microbiome regulates the cells lining our intestines.
It is butyrate that provides the energy to the large intestine to grow, maintain, and protect the intestinal barrier.
Interestingly, certain butyrate-producing bacteria include Rosburia intestinalis and Eubacterium rectale, feed on the intestinal lining to produce butyrate.
Therefore, a healthy intestinal lining is crucial to some of the butyrate-producing bacteria that colonize and feed on it.
Without sufficient butyrate, a leaky gut is inevitable.
Butyrate not only supports the gut barrier but also regulates mast cells and the whole immune system.
The gut immune system needs to mount immune responses to pathogens while maintaining immune tolerance to commensal bacteria and foods.
Butyrate levels determine whether these two seemingly competing needs can be achieved.
High levels of butyrate:
Without sufficient butyrate, Th2 dominance, autoimmunity, and mast-cell activation are inevitable.
Butyrate is an energy source, not only for the gut, for the remainder of the body, and it also regulates energy homeostasis throughout the body.
Butyrate is the primary energy source for the intestines, which consume up to 95% of butyrate.
Butyrate then enters the liver and fat tissues, where it regulates whole-body energy homeostasis.
High levels of butyrate result in metabolic programming. Butyrate;
Interestingly, aside from being produced by bacterial fermentation, butyrate can also be produced in smaller amounts by our cells through fatty acid oxidation itself.
Without sufficient butyrate, energy dis-homeostasis is inevitable, resulting in obesity, metabolic syndrome, fatty liver, and mitochondrial issues.
The brain is a site of immense energy demands.
Butyrate not only crosses the blood-brain barrier but there are SCFA transporters and receptors in the brain.
While research is still emerging, studies to date all point to butyrate playing a significant role in both the brain and the gut-brain axis.
High levels of butyrate;
All of these points to butyrate play an essential role in providing the energy the brain needs to maintain homeostasis in the brain and communicate with the gut-brain axis.
The mechanism of action of butyrate is still emerging.
However, the degree of the interface between butyrate and the body is truly astounding.
Fundamental mechanisms of action include:
Simply put, there are few genes, cells, and functions not regulated by butyrate levels.
Fortunately, there are many ways to increase the levels of butyrate with foods, fibers, probiotics, and direct supplementation.
Butyrate is also produced in an animal's gut and transferred via its milk.
Butyrate occurs naturally in whole cow's milk, butter, ghee, cheese (especially goat's cheese), and human breast milk.
Most whole grains, fruit, and vegetables have prebiotic fibers to some extent.
However, foods that particularly feed butyrate-producing bacteria include:
Prebiotics are food supplements that produce butyrate in the gut through microbial fermentation.
Hyper producers of butyrate are:
The products with these prebiotics are:
I use all three and rotate them as they feed different bacteria. Zinobiotic is not suitable for individuals with small intestinal overgrowths.
There has been limited research undertaken into probiotics that cross-feed with butyrate-producing bacteria.
Lactobacillus Rhammnos GG is one probiotic.
However, MegaSporeBiotic, when combined with MegaPre, produced a 150% increase in butyrate production in clinical studies. That is, together they had a synergistic effect due to the cross-feeding with the whole microbiome.
As MegaSporeBiotic is a quorum-sensing probiotic that restores homeostasis to the microbiome it is my preferred probiotic for increasing butyrate.
Most studies that supplement butyrate directly use sodium butyrate.
There are a plethora of new types of butyrate supplements that have come onto the market. Most marketing materials quote improved bioavailability.
It is important to emphasize that sodium butyrate supplementation will not directly raise butyrate-producing gut bacteria levels. It will simply protect cells from the impact of low butyrate production by the microbiome.
The dosages of sodium butyrate used in the studies vary widely. Studies use doses of between 100 - 1200 mg/kg. Studies also use them via enemas direct to the colon. Pessaries can also likely be used. If you are using other forms with higher bioavailability the dosage will of course vary.
It is important to note that high doses can activate the HPA axis, becoming a stressor, such that it is best to titrate any supplementation. Also, developing brains both whilst pregnant and in children should not be exposed.
Since writing this article a new type of butyrate has become available in Australia. Pure Encapsulations Sunbutyrate has been available in the USA for some time and is actively being used by gastroenterologists in the USA.
It remains my preference to use BodyBio Sodium Butyrate for systemic issues, and Pure Encapsulations Sunbutyrate for gastro-intestinal issues.
In conclusion, SCFA receptors are important regulators of mast-cell and immune function, including neuroinflammation, host energy metabolism, and homeostasis.
There is no commercially available way of measuring butyrate levels.
However, butyrate-producing bacteria, and the firmicutes family, are measured by most complete microbiome mapping tests.
As a general rule butyrate producers should be 25% or more of the microbiome. The higher the inflammation in the body the higher we want butyrate producers.
Whilst demand for butyrate can be inferred from a range of standard blood panel markers including metabolic markers (such as blood glucose, insulin, and triglycerides) and inflammation (raised CRP).
Butyrate levels are amongst the most important markers of health and the ultimate mast-cell stabilizer.
Wang, Chun Chun, et al. "Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs." Innate immunity 24.1 (2018): 40-46.
Mortensen, Frank V., et al. "Short-chain fatty acids stimulate mucosal cell proliferation in the closed human rectum after Hartmann’s procedure." International journal of colorectal disease 14.3 (1999): 150-154.
Hague, A., B. Singh, and C. Paraskeva. "Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate." Gastroenterology 112.3 (1997): 1036-1040.
Canani, Roberto Berni, et al. "Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial." Journal of allergy and clinical immunology 129.2 (2012): 580-582.
Duysburgh, Cindy, et al. "A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro." International journal of pharmaceutics: X 1 (2019): 100021.
Henagan, Tara M., et al. "Sodium butyrate epigenetically modulates high‐fat diet‐induced skeletal muscle mitochondrial adaptation, obesity, and insulin resistance through nucleosome positioning." British journal of pharmacology 172.11 (2015): 2782-2798.
Canfora, Emanuel E., et al. "Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial." Scientific reports 7.1 (2017): 1-12.
Khan, Sabbir, and Gopabandhu Jena. "Sodium butyrate reduces insulin-resistance, fat accumulation and dyslipidemia in type-2 diabetic rat: a comparative study with metformin." Chemico-biological interactions 254 (2016): 124-134.
Li, Robert W., and Cong-Jun Li. "Enhancing butyrate biosynthesis in the gut for health benefits." Butyrate: Food sources, functions and health benefits Hauppauge, NY, USA nova science publishers (2014): 1-23.
Savignac, Helene M., et al. "Prebiotic feeding elevates central brain-derived neurotrophic factor, N-methyl-D-aspartate receptor subunits, and D-serine." Neurochemistry international 63.8 (2013): 756-764.
Kao, Amy Chia-Ching, et al. "Prebiotic reduction of brain histone deacetylase (HDAC) activity and olanzapine-mediated weight gain in rats, are acetate independent." Neuropharmacology 150 (2019): 184-191.
Mika, Agnieszka, et al. "Feeding the developing brain: Juvenile rats fed a diet rich in prebiotics and bioactive milk fractions exhibit reduced anxiety-related behavior and modified gene expression in emotion circuits." Neuroscience Letters 677 (2018): 103-109.
Burokas, Aurelijus, et al. "Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice." Biological Psychiatry 82.7 (2017): 472-487.
van den Berg, Jolice P., et al. "Neurodevelopment of preterm infants at 24 months after neonatal supplementation of a prebiotic mix: A randomized trial." Journal of pediatric gastroenterology and nutrition 63.2 (2016): 270-276.
Yang, Tao, et al. "Impaired butyrate absorption in the proximal colon, low serum butyrate and diminished central effects of butyrate on blood pressure in spontaneously hypertensive rats." Acta Physiologica 226.2 (2019): e13256.
Val‐Laillet, David, et al. "Oral sodium butyrate impacts brain metabolism and hippocampal neurogenesis, with limited effects on gut anatomy and function in pigs." The FASEB Journal 32.4 (2018): 2160-2171.
Byrne, Claire S., et al. "Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods." The American journal of clinical nutrition 104.1 (2016): 5-14.
Mitchell, Ryan W., et al. "Fatty acid transport protein expression in the human brain and potential role in fatty acid transport across human brain microvessel endothelial cells." Journal of neurochemistry 117.4 (2011): 735-746.
Lattal, K. Matthew, Ruth M. Barrett, and Marcelo A. Wood. "Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction." Behavioral neuroscience 121.5 (2007): 1125.
Fehlbaum, Sophie, et al. "In vitro fermentation of selected prebiotics and their effects on the composition and activity of the adult gut microbiota." International journal of molecular sciences 19.10 (2018): 3097.
Kratsman, Neta, Dmitriy Getselter, and Evan Elliott. "Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model." Neuropharmacology 102 (2016): 136-145.